Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
position The Laboratory of Causal Systems Immunology is looking for a PhD student or postdoctoral researcher to advance in vivo perturbational screening. We have developed single-cell CRISPR technologies
-
regulator of cell differentiation and stemness. Aberrant differentiation leads to developmental defects and cancer. We hypothesize that aberrant differentiation that is perturbed by abnormal Wnt/β-catenin
-
Hematopoietic stem cells (HSCs) ensure the lifelong production of all blood cell types. With age, HSCs undergo functional and molecular changes that impair their regenerative capacity and contribute
-
engineering, bioengineering, neuroscience, cell biology, electrical engineering, or a related field. Hands-on experience with mammalian cell culture, preferably neuronal or stem-cell-derived cultures
-
Parkinson’s disease. Central to this effort are CRISPR screens that identify genes that make neurons more vulnerable or resilient to stress. These screens will use human induced pluripotent stem cell (iPSC
-
Welcome to Maastricht University! We have developed a new class of oncology drugs that exploit the tumour microenvironment for selective activation that target the NOTCH stem-cell pathway in cancer
-
molecular structures during normal and leukemic stem cell differentiation. Integrated in the translational research environment at the Center for Hematology and Regenerative Medicine at the Karolinska
-
Position overview Position title: Project Scientist - Stem Cell and Regenerative Medicine Salary range: A reasonable salary range estimate for this position is $74,100 - $119,600. The posted UC
-
Anne T. and Robert M. Bass Professorship of Developmental & Stem Cell Biology as Applied to Medicine
postgraduate degree (PhD or equivalent) and an exceptional record of research achievement in developmental and stem cell biology and a compelling vision for its application to human disease. You will bring
-
. Professor Mariya Moosajee and her team are working to advance our understanding of IRDs by generating human disease models using induced pluripotent stem cell technology to derive patient retinal organoids